137 related articles for article (PubMed ID: 19353846)
1. Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases.
Teijeira S; San Millán B; Fernández JM; Rivas E; Viéitez I; Miranda S; González F; Navarro C
Clin Neuropathol; 2009; 28(2):136-42. PubMed ID: 19353846
[TBL] [Abstract][Full Text] [Related]
2. [Myoadenylate deaminase deficiency in a child with myalgias induced by physical exercise].
Pantoja-Martínez J; Navarro Fernández-Balbuena C; Gormaz-Moreno M; Quintans-Castro B; Esparza-Sánchez MA; Bonet-Arzo J
Rev Neurol; 2004 Sep 1-15; 39(5):431-4. PubMed ID: 15378456
[TBL] [Abstract][Full Text] [Related]
3. Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies.
Mercelis R; Martin JJ; de Barsy T; Van den Berghe G
J Neurol; 1987 Aug; 234(6):385-9. PubMed ID: 3655841
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene.
Fischer S; Drenckhahn C; Wolf C; Eschrich K; Kellermann S; Froster UG; Schober R
Clin Neuropathol; 2005; 24(2):77-85. PubMed ID: 15803807
[TBL] [Abstract][Full Text] [Related]
5. Familial myoadenylate deaminase deficiency and exertional myalgia.
Kelemen J; Rice DR; Bradley WG; Munsat TL; DiMauro S; Hogan EL
Neurology; 1982 Aug; 32(8):857-63. PubMed ID: 7201581
[TBL] [Abstract][Full Text] [Related]
6. Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.
Rannou F; Scotet V; Marcorelles P; Monnoyer R; Le Maréchal C
PLoS One; 2017; 12(11):e0187266. PubMed ID: 29095874
[TBL] [Abstract][Full Text] [Related]
7. Genetic characteristics of myoadenylate deaminase deficiency.
Verzijl HT; van Engelen BG; Luyten JA; Steenbergen GC; van den Heuvel LP; ter Laak HJ; Padberg GW; Wevers RA
Ann Neurol; 1998 Jul; 44(1):140-3. PubMed ID: 9667605
[TBL] [Abstract][Full Text] [Related]
8. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Gross M; Rötzer E; Kölle P; Mortier W; Reichmann H; Goebel HH; Lochmüller H; Pongratz D; Mahnke-Zizelman DK; Sabina RL
Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
[TBL] [Abstract][Full Text] [Related]
9. Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabeculation/non-compaction.
Finsterer J; Schoser B; Stöllberger C
Acta Cardiol; 2004 Aug; 59(4):453-6. PubMed ID: 15368811
[TBL] [Abstract][Full Text] [Related]
10. Myoadenylate deaminase deficiency.
Goebel HH; Bardosi A; Conrad B; Kuhlendahl HD; DiMauro S; Rumpf KW
Klin Wochenschr; 1986 Apr; 64(7):342-7. PubMed ID: 3713108
[TBL] [Abstract][Full Text] [Related]
11. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.
Gross M
J Inherit Metab Dis; 1997 Jun; 20(2):186-92. PubMed ID: 9211191
[TBL] [Abstract][Full Text] [Related]
12. Myoadenylate deaminase deficiency: a frequent cause of muscle pain A case detected by exercise testing.
Lim L; Palayer M; Bruneau A; Letournel F; Le Maréchal C; Simard G; Reynier P; Homedan C; Nadaj-Pakleza A
Ann Biol Clin (Paris); 2017 Aug; 75(4):445-449. PubMed ID: 28751290
[TBL] [Abstract][Full Text] [Related]
13. Myoadenylate deaminase deficiency: a new disease of muscle.
Fishbein WN; Armbrustmacher VW; Griffin JL
Science; 1978 May; 200(4341):545-8. PubMed ID: 644316
[TBL] [Abstract][Full Text] [Related]
14. Levels of adenylate deaminase, adenylate kinase, and creatine kinase in frozen human muscle biopsy specimens relative to type 1/type 2 fiber distribution: evidence for a carrier state of myoadenylate deaminase deficiency.
Fishbein WN; Armbrustmacher VW; Griffin JL; Davis JI; Foster WD
Ann Neurol; 1984 Mar; 15(3):271-7. PubMed ID: 6326659
[TBL] [Abstract][Full Text] [Related]
15. Exercise testing-based algorithms to diagnose McArdle disease and MAD defects.
Noury JB; Zagnoli F; Carré JL; Drouillard I; Petit F; Le Maréchal C; Marcorelles P; Rannou F
Acta Neurol Scand; 2018 Oct; 138(4):301-307. PubMed ID: 29749052
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and immunologic evidence for a complete gene block in myoadenylate deaminase deficiency.
Fishbein WN; Davis JI; Foellmer JW
J Exp Pathol; 1983; 1(1):7-25. PubMed ID: 6086015
[TBL] [Abstract][Full Text] [Related]
17. Myotonia congenita and myoadenylate deaminase deficiency: case report.
Scola RH; Iwamoto FM; Camargo CH; Arruda WO; Werneck LC
Arq Neuropsiquiatr; 2003 Jun; 61(2A):262-4. PubMed ID: 12806508
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study.
Rannou F; Uguen A; Scotet V; Le Maréchal C; Rigal O; Marcorelles P; Gobin E; Carré JL; Zagnoli F; Giroux-Metges MA
PLoS One; 2015; 10(7):e0132972. PubMed ID: 26207760
[TBL] [Abstract][Full Text] [Related]
19. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
[TBL] [Abstract][Full Text] [Related]
20. Myoadenylate deaminase deficiency with severe rhabdomyolysis.
Baumeister FA; Gross M; Wagner DR; Pongratz D; Eife R
Eur J Pediatr; 1993 Jun; 152(6):513-5. PubMed ID: 8335021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
